EGFR and lung carcinoma: On the other hand, it was also shown that the IL‐6/JAK/STAT3 signaling pathway‐mediated PD‐L1 increase in lung cancer cells was via activation of EGFR‐tyrosine kinase (Zhang et al., 2016).